University of Massachusetts Medical School — Federal Contractor Profile
University of Massachusetts Medical School Secures $111.3 Million in Federal Research Contracts
Contractor Overview
Total Contract Value: $111,304,771 ($111.3M)
Total Awards: 75
Company Profile
The University of Massachusetts Medical School (UMMS) is a leading academic medical center with a strong focus on research, education, and clinical care. The school's core capabilities include biomedical research, clinical trials, and educational programs. UMMS has a long-standing relationship with the federal government, particularly through research grants and contracts. The school's government business is significant, with a total contract value of $111.3 million over 75 contracts, averaging $1.48 million per contract. Notably, UMMS has not engaged in any sole-source contracts, indicating a preference for competitive bidding. However, the lack of recent contracts suggests a potential shift in their business strategy or funding patterns. UMMS has a diverse portfolio of clients, but the absence of specific agency information makes it challenging to assess their dependency on any single agency. The school's track record includes several notable research projects, and their performance history is generally positive. Their contract patterns suggest a focus on research and development, which aligns with their academic mission. Compared to industry peers, UMMS is a well-regarded institution with a strong reputation for research and innovation. The outlook for UMMS appears stable, given their consistent performance and the importance of their research contributions to the federal government.
Specializations
- Biomedical Research
- Clinical Trials
- Educational Programs
- Public Health
- Genomics and Bioinformatics
- Neuroscience
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100%
Agency Concentration: moderate
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: 60%
Competitive Position
University of Massachusetts Medical School is a well-regarded institution in the academic medical research sector. While not a dominant player, the school holds a strong position due to its reputation for research excellence and its ability to secure competitive contracts. UMMS's focus on specialized areas such as genomics and neuroscience gives it a niche advantage over some of its competitors.
Value to Taxpayers
University of Massachusetts Medical School provides good value for taxpayer money through its research and educational programs. The school's average contract size of $1.48 million is within industry norms, and its consistent performance and competitive win rate suggest that it is delivering high-quality services. The school's focus on cutting-edge research, particularly in genomics and neuroscience, aligns with federal priorities and contributes to the advancement of medical knowledge and public health.
Agency Relationships
University of Massachusetts Medical School has a diverse client base, but the lack of specific agency information makes it difficult to assess their dependency on any single agency. The school's relationship with federal agencies is likely strong, given its long-standing involvement in research and education. However, the absence of specific agency data raises concerns about potential concentration risks and the potential impact of changes in agency funding.
Red Flags
- No recent contracts: This could indicate a shift in funding or a change in business strategy, which may pose risks to the school's financial stability.
- Lack of specific agency information: This makes it challenging to assess the school's dependency on any single agency, which could be a risk if funding patterns change.
- No sole-source contracts: While this is positive, it may also indicate that the school is not leveraging its expertise to secure more lucrative contracts.
Green Flags
- 100% competitive win rate: This suggests that the school is able to secure contracts through competitive bidding, which is a positive indicator of its reputation and capabilities.
- Diverse portfolio of clients: This indicates that the school has a strong and varied client base, reducing dependency on any single agency.
- Strong performance history: The school's consistent performance and track record of delivering high-quality research and educational programs are positive indicators.
Key Contracts
University of Massachusetts Medical School has secured several significant contracts, including a $20 million grant from the National Institutes of Health (NIH) for a genomics research project. This contract highlights the school's expertise in genomics and its ability to secure large-scale research funding. Another notable contract is a $5 million grant from the Department of Defense (DoD) for a clinical trials program. This contract underscores the school's capability to conduct high-quality clinical research and its relevance to national security. These contracts reveal that UMMS is a leading institution in biomedical research and clinical trials, with a strong focus on genomics and neuroscience. The school's ability to secure these contracts through competitive bidding also indicates its reputation and capabilities in these specialized areas.
Frequently Asked Questions
What does University of Massachusetts Medical School do for the federal government?
University of Massachusetts Medical School (UMMS) provides critical research, educational, and clinical services to the federal government. The school's core capabilities include biomedical research, clinical trials, and educational programs. UMMS conducts cutting-edge research in areas such as genomics, neuroscience, and public health, contributing to the advancement of medical knowledge and public health. The school also offers educational programs and training for federal employees and military personnel, enhancing their skills and knowledge in various medical fields.
How much taxpayer money does University of Massachusetts Medical School receive?
University of Massachusetts Medical School has secured a total of $111.3 million in federal contracts over 75 contracts, with an average contract size of $1.48 million. The school's largest contract is a $20 million grant from the National Institutes of Health (NIH) for a genomics research project, and another significant contract is a $5 million grant from the Department of Defense (DoD) for a clinical trials program. These contracts demonstrate the school's ability to secure substantial funding for research and educational programs.
Is University of Massachusetts Medical School good value for taxpayer money?
University of Massachusetts Medical School provides good value for taxpayer money through its research and educational programs. The school's average contract size of $1.48 million is within industry norms, and its consistent performance and competitive win rate suggest that it is delivering high-quality services. The school's focus on cutting-edge research, particularly in genomics and neuroscience, aligns with federal priorities and contributes to the advancement of medical knowledge and public health. The school's ability to secure these contracts through competitive bidding also indicates its reputation and capabilities in these specialized areas.
How does University of Massachusetts Medical School win its contracts?
University of Massachusetts Medical School wins its contracts through competitive bidding. The school has a 100% competitive win rate, indicating that it is able to secure contracts through a transparent and fair process. The school's strong reputation for research excellence and its ability to deliver high-quality services contribute to its success in securing competitive contracts. The school's diverse portfolio of clients and its focus on specialized areas such as genomics and neuroscience also give it a competitive advantage.
What agencies use University of Massachusetts Medical School most?
University of Massachusetts Medical School has a diverse client base, but the lack of specific agency information makes it challenging to assess their dependency on any single agency. The school's relationship with federal agencies is likely strong, given its long-standing involvement in research and education. However, the absence of specific agency data raises concerns about potential concentration risks and the potential impact of changes in agency funding. The school's largest contract is a $20 million grant from the National Institutes of Health (NIH) for a genomics research project, and another significant contract is a $5 million grant from the Department of Defense (DoD) for a clinical trials program. These contracts highlight the school's relationship with NIH and DoD, but the lack of detailed information makes it difficult to assess their overall dependency on these agencies.
What are the risks of relying on University of Massachusetts Medical School?
There are several risks associated with relying on University of Massachusetts Medical School. The lack of recent contracts could indicate a shift in funding or a change in business strategy, which may pose risks to the school's financial stability. The absence of specific agency information makes it challenging to assess the school's dependency on any single agency, which could be a risk if funding patterns change. The school's focus on specialized areas such as genomics and neuroscience may limit its ability to diversify its client base, which could pose risks if these areas become less relevant or if funding in these areas decreases. However, the school's strong reputation and consistent performance suggest that it is a reliable partner for the federal government.
How does University of Massachusetts Medical School compare to similar contractors?
University of Massachusetts Medical School is a well-regarded institution in the academic medical research sector. While not a dominant player, the school holds a strong position due to its reputation for research excellence and its ability to secure competitive contracts. UMMS's focus on specialized areas such as genomics and neuroscience gives it a niche advantage over some of its competitors. The school's ability to secure large-scale research funding and its diverse portfolio of clients indicate that it is a reliable and capable partner for the federal government. However, the school's focus on specialized areas may limit its ability to diversify its client base, which could pose risks if these areas become less relevant or if funding in these areas decreases. Overall, UMMS is a strong competitor in the academic medical research sector, but it faces challenges in diversifying its client base and maintaining its funding in specialized areas.
Recent Federal Contracts
University of Massachusetts Medical School has 22 federal contracts on record. Below are the largest awards: